Literature DB >> 7608802

Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy.

T P Stevens1, R Guillet.   

Abstract

Labetalol is used to treat hypertensive crisis in women with preeclampsia. Glucagon was used as a nonselective beta-adrenergic agonist to treat a preterm infant with symptomatic beta-blockade caused by maternal labetalol therapy.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7608802     DOI： 10.1016/s0022-3476(95)70277-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  3 in total

1.  Adverse neonatal effects of maternal labetalol treatment.

Authors:  B N Crooks; S A Deshpande; C Hall; M P Platt; D W Milligan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

2.  Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.

Authors:  Laura A Magee; Chris Cham; Elizabeth J Waterman; Arne Ohlsson; Peter von Dadelszen
Journal:  BMJ       Date:  2003-10-25

Review 3.  The Risk for Neonatal Hypoglycemia and Bradycardia after Beta-Blocker Use during Pregnancy or Lactation: A Systematic Review and Meta-Analysis.

Authors:  Rosalie de Bruin; Sarah L van Dalen; Shamaya J Franx; Viraraghavan V Ramaswamy; Sinno H P Simons; Robert B Flint; Gerbrich E van den Bosch
Journal:  Int J Environ Res Public Health       Date:  2022-08-04       Impact factor: 4.614
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.